| 000 | 01830 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517123445.0 | ||
| 264 | 0 | _c20170904 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1873-3344 | ||
| 024 | 7 |
_a10.1016/j.jinorgbio.2016.10.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBasu Baul, Tushar S | |
| 245 | 0 | 0 |
_aNew dibutyltin(IV) ladders: Syntheses, structures and, optimization and evaluation of cytotoxic potential employing A375 (melanoma) and HCT116 (colon carcinoma) cell lines in vitro. _h[electronic resource] |
| 260 |
_bJournal of inorganic biochemistry _c01 2017 |
||
| 300 |
_a34-48 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Membrane _xmetabolism |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 |
_aCytotoxins _xchemical synthesis |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 |
_aMembrane Fluidity _xdrug effects |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aOrganotin Compounds _xchemical synthesis |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 700 | 1 | _aDutta, Dhrubajyoti | |
| 700 | 1 | _aDuthie, Andrew | |
| 700 | 1 | _aGuchhait, Nikhil | |
| 700 | 1 | _aRocha, Bruno G M | |
| 700 | 1 | _aGuedes da Silva, M Fátima C | |
| 700 | 1 | _aMokhamatam, Raveendra B | |
| 700 | 1 | _aRaviprakash, Nune | |
| 700 | 1 | _aManna, Sunil K | |
| 773 | 0 |
_tJournal of inorganic biochemistry _gvol. 166 _gp. 34-48 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jinorgbio.2016.10.008 _zAvailable from publisher's website |
| 999 |
_c26579442 _d26579442 |
||